<?xml version="1.0"?>
<xml><ArticleSet><Article><Journal><PublisherName>Radiance Research Academy</PublisherName><JournalTitle>International Journal of Current Research and Review</JournalTitle><PISSN>2231-2196</PISSN><EISSN>0975-5241</EISSN><Volume>15</Volume><Issue>1</Issue><IssueLanguage>English</IssueLanguage><SpecialIssue>N</SpecialIssue><PubDate><Year>2023</Year><Month>January</Month><Day>7</Day></PubDate></Journal><ArticleType>Healthcare</ArticleType><ArticleTitle>&#xD;
	Aspergillus and the Role of Cytopathology and Microbiology Lab Techniques in Diagnosis&#xD;
&#xD;
</ArticleTitle><ArticleLanguage>English</ArticleLanguage><FirstPage>01</FirstPage><LastPage>10</LastPage><AuthorList><Author>Almutiri Abdullah Bandar</Author><AuthorLanguage>English</AuthorLanguage><Author> Mohammed M Alanazi</Author><AuthorLanguage>English</AuthorLanguage><Author> M. ALMUTERY</Author><AuthorLanguage>English</AuthorLanguage><Author> Mubarak Alqahtani</Author><AuthorLanguage>English</AuthorLanguage><Author> Salman Muyidi</Author><AuthorLanguage>English</AuthorLanguage><Author> Mousa haqawi</Author><AuthorLanguage>English</AuthorLanguage><Author> Fahad Alhusain</Author><AuthorLanguage>English</AuthorLanguage></AuthorList><Abstract>&#xD;
	Introduction: Aspergillosis is a type of fungal infection or a type of mold that can cause serious respiratory illnesses in people especially those with weakened immune systems. Timely diagnosis and treatment of Aspergillus infections is critical to preventing potentially life-threatening complications. It can be difficult to diagnose, as it often mimics other diseases. Cytopathology and microbiology lab techniques can be used to help diagnose aspergillosis; Histopathology, PCR and biochemistry are also important. Aims: To compare the most effective laboratory diagnostic techniques to detect the Aspergillus in body. Methods: This systematic review searched for studies that evaluated the use of cytopathology and microbiology and other lab techniques in the diagnosis of aspergillosis. Studies were identified through searches of Google Scholar, MEDLINE, EMBASE, and the Cochrane Library. Results: Cytopathology and microbiology lab techniques can both be helpful in diagnosing aspergillosis. Cytopathology and histopathology are both highly accurate, but results may take longer to obtain than with other tests. Microbiology is useful for diagnosing infections, but it may not be as accurate as cytopathology or histopathology. Poly Chain Reaction (PCR) is very accurate, but it is also expensive and results may take some time to obtain. Biochemistry can be useful for diagnosing metabolic disorders, but it is not as accurate as other tests. Conclusion: There is no one &#x201C;best&#x201D; way to detect Aspergillus, and the best approach may vary depending on the particular patient and situation. In general, a combination of two or more tests may be needed to accurately diagnose aspergillosis. The most important factor/guideline in choosing which tests to use is whether they will provide information that can help guide treatment decisions. Nevertheless, with all factors considered the PCR is the best test because it is highly sensitive and specific; able to detect even low levels of Aspergillus.&#xD;
&#xD;
</Abstract><AbstractLanguage>English</AbstractLanguage><Keywords>Aspergillus, Aspergillosis, PCR, Microbiology, Cytopathology, Infection</Keywords><URLs><Abstract>http://ijcrr.com/abstract.php?article_id=4674</Abstract><Fulltext>http://ijcrr.com/article_html.php?did=4674</Fulltext></URLs><References>&#xD;
	1. Warris A. The biology of pulmonary Aspergillus infections. J. Infect. Dis. [2014] Nov 1;69:S36-41. &#xD;
&#xD;
&#xD;
&#xD;
	2. King J, Brunel SF, Warris A. Aspergillus infections in cystic fibrosis. J. Infect. Dis. 2016 Jul 5;72:S50-5.&#xD;
&#xD;
&#xD;
&#xD;
	3. El-Baba F, Gao Y, Soubani AO. Pulmonary aspergillosis: what the generalist needs to know. Am J Med. 2020 Jun 1;133(6):668- 74. &#xD;
&#xD;
&#xD;
&#xD;
	4. Agarwal R, Sehgal IS, Dhooria S, Aggarwal AN. Developments in the diagnosis and treatment of allergic bronchopulmonary aspergillosis. Expert Review of Respiratory Medicine. 2016 Dec 1;10(12):1317-34. &#xD;
&#xD;
&#xD;
&#xD;
	5. Barnes RA, White PL, Morton CO, Rogers TR, Cruciani M, Loeffler J, Donnelly JP. Diagnosis of aspergillosis by PCR: clinical considerations and technical tips. Medical mycology. 2018 Apr 1;56(suppl_1):S60-72. &#xD;
&#xD;
&#xD;
&#xD;
	6. Denning DW, Cadranel J, Beigelman-Aubry C, Ader F, Chakrabarti A, Blot S, Ullmann AJ, Dimopoulos G, Lange C. Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management. Eur Respir J. 2016 Jan 1;47(1):45-68.&#xD;
&#xD;
&#xD;
&#xD;
	7. Zmeili OS, Soubani AO. Pulmonary aspergillosis: a clinical update. J Assoc Physicians India. 2007 Jun 1;100(6):317-34.&#xD;
&#xD;
&#xD;
&#xD;
	8. Gochhait D, Dey P, Rajwanshi A, Nijhawan R, Radhika S, Gupta N. Spectrum of fungal and parasitic infections on fine needle aspiration cytology. Diagnostic Cytopathology. 2015 Jun;43(6):450-5. &#xD;
&#xD;
&#xD;
&#xD;
	9. Sharma S, Gupta P, Gupta N, Lal A, Behera D, Rajwanshi A. Pulmonary infections in immunocompromised patients: the role of image-guided fine needle aspiration cytology. Cytopathology. 2017 Feb;28(1):46-54. &#xD;
&#xD;
&#xD;
&#xD;
	10. Nerune SM, Arora S, Kumar M. Cytological Diagnosis of Primary Cutaneous Aspergillosis Masquerading as Lipoma in a Known Case of Lepromatous Leprosy. J Clin Diagn Res: JCDR. 2017 May;11(5):ED36. &#xD;
&#xD;
&#xD;
&#xD;
	11. Cox G, Kauffman C, Hall K. [Internet]. Mucormycosis (zygomycosis). 2022 [cited 2022 Nov16]. Available from: https:// www.uptodate.com/contents/mucormycosis-zygomycosis &#xD;
&#xD;
&#xD;
&#xD;
	12. Emmanuel P. Mucormycosis pathology [Internet]. DermNet. 2022 [cited 2022Nov16]. Available from: https://dermnetnz.org/ topics/mucormycosis-pathology &#xD;
&#xD;
&#xD;
&#xD;
	13. Klimko N, Khostelidi S, Shadrivova O, Volkova A, Popova M, Uspenskaya O, Shneyder T, Bogomolova T, Ignatyeva S, Zubarovskaya L, Afanasyev B. Contrasts between mucormycosis and aspergillosis in oncohematological patients. Medical Mycology. 2019 Apr 1;57(Supplement_2):S138-44. &#xD;
&#xD;
&#xD;
&#xD;
	14. Trief D, Gray ST, Jakobiec FA, Durand ML, Fay A, Freitag SK, Lee NG, Lefebvre DR, Holbrook E, Bleier B, Sadow P. Invasive fungal disease of the sinus and orbit: a comparison between mucormycosis and Aspergillus. Br J Ophthalmol. 2016 Feb 1;100(2):184-8. &#xD;
&#xD;
&#xD;
&#xD;
	15. Jung J, Park YS, Sung H, Song JS, Lee SO, Choi SH, Kim YS, Woo JH, Kim SH. Using immunohistochemistry to assess the accuracy of histomorphologic diagnosis of aspergillosis and mucormycosis. Clinical Infectious Diseases. 2015 Dec 1;61(11):1664-70. &#xD;
&#xD;
&#xD;
&#xD;
	16. Lahmer T, Messer M, Ehmer U, Eser S, Beitz A, Fekecs L, Schmid RM, Huber W. Pseudallescheria boydii with Aspergillus fumigatus and Aspergillus terreus in a critically ill hematopoietic stem cell recipient with ARDS. Mycopathologia. 2016 Apr;181(3):267-71. &#xD;
&#xD;
&#xD;
&#xD;
	17. LAM SM, LAU AC, MA MW, YAM LY. Pseudallescheria boydii or Aspergillus fumigatus in a lady with an unresolving lung infiltrate, and a literature review. Respirology. 2008 May;13(3):478-80. &#xD;
&#xD;
&#xD;
&#xD;
	18. Chidambaram JD, Prajna NV, Larke N, Macleod D, Srikanthi P, Lanjewar S, Shah M, Lalitha P, Elakkiya S, Burton MJ. In vivo confocal microscopy appearance of Fusarium and Aspergillus species in fungal keratitis. Br J Ophthalmol. 2017 Aug 1;101(8):1119-23. &#xD;
&#xD;
&#xD;
&#xD;
	19. Vento S, Cainelli F, Temesgen Z. Lung infections after cancer chemotherapy. The lancet oncology. 2008 Oct 1;9(10):982-92. &#xD;
&#xD;
&#xD;
&#xD;
	20. Muraosa Y, Schreiber AZ, Trabasso P, Matsuzawa T, Taguchi H, Moretti ML, Mikami Y, Kamei K. Development of cycling probe-based real-time PCR system to detect Fusarium species and Fusarium solani species complex (FSSC). Int. J. Med. Microbiol. Suppl. 2014 May 1;304(3-4):505-11. &#xD;
&#xD;
&#xD;
&#xD;
	21. Verweij PE, Smedts F, Poot T, Bult P, Hoogkamp-Korstanje JA, Meis JF. Immunoperoxidase staining for identification of Aspergillus species in routinely processed tissue sections. J. Clin. Pathol. 1996 Oct 1;49(10):798-801. &#xD;
&#xD;
&#xD;
&#xD;
	22. Bulpa P, Dive A, Sibille Y. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Eur Respir J. 2007 Oct 1;30(4):782-800. &#xD;
&#xD;
&#xD;
&#xD;
	23. Romett JL, Newman RK. Aspergillosis of the nose and paranasal sinuses. The Laryngoscope. 1982 Jul;92(7):764-6. &#xD;
&#xD;
&#xD;
&#xD;
	24. Tillie-Leblond I, Tonnel AB. Allergic bronchopulmonary aspergillosis. Allergy. 2005 Aug;60(8):1004-13. &#xD;
&#xD;
&#xD;
&#xD;
	25. Holdom MD, Hay RJ, Hamilton AJ. The Cu, Zn superoxide dismutases of Aspergillus flavus, Aspergillus niger, Aspergillus nidulans, and Aspergillus terreus: purification and biochemical comparison with the Aspergillus fumigatus Cu, Zn superoxide dismutase. Infection and Immunity. 1996 Aug;64(8):3326-32. &#xD;
&#xD;
&#xD;
&#xD;
	26. Filtenborg O, Frisvad JC. Identification of Penicillium and Aspergillus species in mixed cultures in Petri dishes using secondary metabolite profile. Modern Concepts in Penicillium and Aspergillus Classification 1990 (pp. 27-37). Springer, Boston, MA. &#xD;
&#xD;
&#xD;
&#xD;
	27. Rosa C, Araujo R, Rodrigues AG, Pinto-de-Sousa MI, Pina-Vaz C. Detection of Aspergillus species in BACTEC blood cultures. J. Med. Microbiol. 2011 Oct 1;60(10):1467-71. &#xD;
&#xD;
&#xD;
&#xD;
	28. Arvanitis M, Anagnostou T, Mylonakis E. Galactomannan and polymerase chain reaction&#x2013;based screening for invasive aspergillosis among high-risk hematology patients: a diagnostic meta-analysis. Clinical Infectious Diseases. 2015 Oct 15;61(8):1263- 72. &#xD;
&#xD;
&#xD;
&#xD;
	29. Cruciani M, Mengoli C, Barnes R, Donnelly JP, Loeffler J, Jones BL, Klingspor L, Maertens J, Morton CO, White LP. Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people. Cochrane Database of Systematic Reviews. 2019(9). &#xD;
&#xD;
&#xD;
&#xD;
	30. de Castro RJ, Nishide TG, Sato HH. Production and biochemical properties of proteases secreted by Aspergillus niger under solid state fermentation in response to different agroindustrial substrates. Biocatalysis and Agricultural Biotechnology. 2014 Oct 1;3(4):236-45. &#xD;
&#xD;
&#xD;
&#xD;
	31. Venugopal TV, Venugopal PV. Primary cutaneous aspergillosis&#xA0;from Tamilnadu was diagnosed by fine needle aspiration cytology. Medical mycology case reports. 2012 Jan 1;1(1):103-6. &#xD;
&#xD;
&#xD;
&#xD;
	32. Shen Y, Zhang X, Lin W, Wan C, Li Q, Jiang Y. Liquid-based cytopathology test as a novel method to identify Aspergillus in patients with pulmonary aspergillosis. Scientific Reports. 2017 Aug 8;7(1):1-8. &#xD;
&#xD;
&#xD;
&#xD;
	33. Fern&#xE1;ndez-Cruz A, Magira E, Heo ST, Evans S, Tarrand J, Kontoyiannis DP. Bronchoalveolar lavage fluid cytology in culture documented invasive pulmonary aspergillosis in patients with hematologic diseases: analysis of 67 episodes. J. Clin. Microbiol. 2018 Oct 1;56(10):e00962-18. &#xD;
&#xD;
&#xD;
&#xD;
	34. Sharma D, Mahajan N, Rao S, Khurana N, Jain S. Invasive maxillary aspergillosis masquerading as malignancy in two cases: utility of cytology as a rapid diagnostic tool. J Cytol . 2012 Jul;29(3):194. &#xD;
&#xD;
&#xD;
&#xD;
	35. Tochigi N, Okubo Y, Ando T, Wakayama M, Shinozaki M, Gocho K, Hata Y, Ishiwatari T, Nemoto T, Shibuya K. Histopathological implications of Aspergillus infection in lung. Mediators of Inflammation. 2013 Jan 1;2013. &#xD;
&#xD;
&#xD;
&#xD;
	36. Blot SI, Taccone FS, Van den Abeele AM, Bulpa P, Meersseman W, Brusselaers N, Dimopoulos G, Paiva JA, Misset B, Rello J, Vandewoude K. A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients. Am. J. Respir. Crit. 2012 Jul 1;186(1):56-64. &#xD;
&#xD;
&#xD;
&#xD;
	37. Denning DW, Page ID, Chakaya J, Jabeen K, Jude CM, Cornet M, Alastruey-Izquierdo A, Bongomin F, Bowyer P, Chakrabarti A, Gago S. Case definition of chronic pulmonary aspergillosis in resource-constrained settings. Emerging infectious diseases. 2018 Aug;24(8). &#xD;
&#xD;
&#xD;
&#xD;
	38. Machado M, Valerio M, &#xC1;lvarez-Ur&#xED;a A, Olmedo M, Veintimilla C, Padilla B, De la Villa S, Guinea J, Escribano P, Ruiz Serrano MJ, Reigadas E. Invasive pulmonary aspergillosis in the COVID-19 era: An expected new entity. Mycoses. 2021 Feb;64(2):132-43. &#xD;
&#xD;
&#xD;
&#xD;
	39. Boch, T., Reinwald, M., Spiess, B., Liebregts, T., Schellongowski, P., Meybohm, P., Rath, P.M., Steinmann, J., Trinkmann, F., Britsch, S. and Michels, J.D., 2018. Detection of invasive pulmonary aspergillosis in critically ill patients by combined use of conventional culture, galactomannan, 1-3-beta-D-glucan and Aspergillus specific nested polymerase chain reaction in a prospective pilot study. J. Crit. Care, 47, pp.198-203. &#xD;
&#xD;
&#xD;
&#xD;
	40. Shukry M, Abd El-Kader MF, Hendam BM, Dawood MA, Farrag FA, Aboelenin SM, Soliman MM, Abdel-Latif HM. Dietary Aspergillus oryzae modulates serum biochemical indices, immune responses, oxidative stress, and transcription of HSP70 and cytokine genes in Nile tilapia exposed to salinity stress. Animals. 2021 May 31;11(6):1621. &#xD;
&#xD;
&#xD;
&#xD;
	41. Yu X, Liu Y, Xie X, Zheng XD, Li SM. Biochemical characterization of indole prenyltransferases: filling the last gap of prenylation positions by a 5-dimethylallyl tryptophan synthase from Aspergillus clavatus. J. Biol. Chem. 2012 Jan 6;287(2):1371-80. &#xD;
&#xD;
&#xD;
&#xD;
	42. Page, I. D., Richardson, M., &amp; Denning, D. W. Antibody testing in aspergillosis&#x2014;quo vadis?. Medical mycology,(2015). 53(5), 417-439.&#xD;
&#xD;
</References></Article></ArticleSet><ArticleSet><Article><Journal><PublisherName>Radiance Research Academy</PublisherName><JournalTitle>International Journal of Current Research and Review</JournalTitle><PISSN>2231-2196</PISSN><EISSN>0975-5241</EISSN><Volume>15</Volume><Issue>1</Issue><IssueLanguage>English</IssueLanguage><SpecialIssue>N</SpecialIssue><PubDate><Year>2023</Year><Month>January</Month><Day>7</Day></PubDate></Journal><ArticleType>Healthcare</ArticleType><ArticleTitle>&#xD;
	A Case Report of Rare Disease: Adenocarcinoma Esophagus in 12-years-Old Boy in Children&#x2019;s Hospital, Lahore&#xD;
&#xD;
&#xD;
&#xD;
	&#xA0;&#xD;
&#xD;
&#xD;
&#xD;
	&#xA0;&#xD;
&#xD;
</ArticleTitle><ArticleLanguage>English</ArticleLanguage><FirstPage>11</FirstPage><LastPage>13</LastPage><AuthorList><Author>Alia Ahmad</Author><AuthorLanguage>English</AuthorLanguage><Author> Fariha Sahrish</Author><AuthorLanguage>English</AuthorLanguage><Author> Ayesha Bibi</Author><AuthorLanguage>English</AuthorLanguage><Author> Zainab Ehsan</Author><AuthorLanguage>English</AuthorLanguage><Author> Mahvish Hussain</Author><AuthorLanguage>English</AuthorLanguage></AuthorList><Abstract>&#xD;
	Introduction: Squamous cell carcinoma of the esophagus is more common than adenocarcinoma. It is most common in Asian countries and more prevalent in black population as compared to white population. Its incidence has a decreasing trend, recent years. This disease is very rarely seen in children and adolescents. Case Report: A 12-year-old boy with moderately differentiated adenocarcinoma of lower esophagus is reported because it is a very rare disease in children. Patient presented with vomiting and dysphagia. Surgery was not possible due to widespread disease. Chemotherapy followed by radiotherapy was given. Patient started taking semisolids after two courses of chemotherapy. Discussion: Esophageal carcinoma is disease of old age and most prevalent in Asian countries. Most patients with this disease are male and have age more than 50 years. This disease is very rarely found in children, the youngest patient presented with the disease was eight years old. It frequently metastasizes to lungs, liver and mediastinal lymph nodes.&#xD;
&#xD;
</Abstract><AbstractLanguage>English</AbstractLanguage><Keywords>Esophagus, Dysphagia, Adenocarcinoma, Asia, Squamous cell carcinoma, Mediastinal lymph nodes</Keywords><URLs><Abstract>http://ijcrr.com/abstract.php?article_id=4675</Abstract><Fulltext>http://ijcrr.com/article_html.php?did=4675</Fulltext></URLs><References>&#xD;
	1. He H, Chen N, Hou Y, Wang Z, Zhang Y, Zhang G, et al. Trends in the incidence and survival of patients with esophageal cancer: a SEER database analysis. Thoracic cancer. 2020 May;11(5):1121-8. &#xD;
&#xD;
&#xD;
&#xD;
	2. Xie SH, Lagergren J. Time trends in the incidence of oesophageal cancer in Asia: Variations across populations and histological types. Cancer Epidemiol. 2016;44:71-76. doi:10.1016/j. canep.2016.08.002 &#xD;
&#xD;
&#xD;
&#xD;
	3. Murphy CC, Claire Yang Y, Shaheen NJ, Hofstetter WL, Sandler RS. An age-period-cohort analysis of obesity and incident esophageal adenocarcinoma among white males. Dis Esophagus. 2017;30(3):1-8. doi:10.1111/dote.12526 &#xD;
&#xD;
&#xD;
&#xD;
	4. Kumar P, Dana R, Prashant Dadhich, Mehta V, Chaturvedi MK. A Rare Case Report: Carcinoma Esophagus in 12-year-old Girl with Unknown Etiology. Cancer Ther Oncol Int J. 2019;14(1):1- 3. doi:10.19080/CTOIJ.2019.14.555882 &#xD;
&#xD;
&#xD;
&#xD;
	5. Shahi UP, Dattagupta S, Singhal S, Kumar L, Bahadur S, Rath GK. Carcinoma oesophagus in a 14-year-old child: report of a case and review of literature. Tropical gastroenterology: official journal of the Digestive Diseases Foundation. 1989 Oct 1;10(4):225-8. &#xD;
&#xD;
&#xD;
&#xD;
	6. Allam AR, Fazili FM, Khawaja FI, Sultan A. Esophageal Carcinoma in a 15-Year-Old Girl: A Case Report and Review of the Literature. Ann Saudi Med. 2000;20(3-4):261-264. doi:10.5144/0256-4947.2000.261 &#xD;
&#xD;
&#xD;
&#xD;
	7. Soni NK, Bikaner PC. Carcinoma of the oesophagus in an eight-year-old child.The Journal of Laryngology &amp; Otology. 1980;94(3):327-329. doi:10.1017/S002221510008885X &#xD;
&#xD;
&#xD;
&#xD;
	8. Theilen TM, Chou AJ, Klimstra DS, LaQuaglia MP. Esophageal Adenocarcinoma and Squamous Cell Carcinoma in Children and Adolescents: Report of 3 Cases and Comprehensive Literature Review. J Pediatr Surg Case Rep. 2016;5:23-29. doi:10.1016/j. epsc.2015.12.008 &#xD;
&#xD;
&#xD;
&#xD;
	9. Buckle GC, Mmbaga EJ, Paciorek A, Akoko L, Deardorff K, Mgisha W, et al. Risk factors associated with early-onset esophageal cancer in Tanzania. JCO Global Oncology. 2022 Feb;8:e2100256. doi:10.1200/GO.21.00256 &#xD;
&#xD;
&#xD;
&#xD;
	10. Hu N, Wang K, Zhang L, Liu ZJ, Jin Z, Cui RL et al.Epidemiological and clinical features of functional dyspepsia in a region with a high incidence of esophageal cancer in China. Chin Med J (Engl). 2021 Jun 20;134(12):1422-30. doi:10.1097/ CM9.0000000000001584 &#xD;
&#xD;
&#xD;
&#xD;
	11. Luo LN, He LJ, Gao XY, Huang XX, Shan HB, Luo GY et al. Evaluation of preoperative staging for esophageal squamous cell carcinoma. World J Gastroenterol. 2016 Aug 8;22(29):6683-9. doi:10.3748/wjg.v22.i29.6683&#xD;
&#xD;
</References></Article></ArticleSet><ArticleSet><Article><Journal><PublisherName>Radiance Research Academy</PublisherName><JournalTitle>International Journal of Current Research and Review</JournalTitle><PISSN>2231-2196</PISSN><EISSN>0975-5241</EISSN><Volume>15</Volume><Issue>1</Issue><IssueLanguage>English</IssueLanguage><SpecialIssue>N</SpecialIssue><PubDate><Year>2023</Year><Month>January</Month><Day>7</Day></PubDate></Journal><ArticleType>Healthcare</ArticleType><ArticleTitle>&#xD;
	Rescue Balloon Aortic Valvuloplasty for Malignant Ventricular Arrhythmias and Cardiogenic Shock&#xD;
&#xD;
&#xD;
&#xD;
	&#xA0;&#xD;
&#xD;
&#xD;
&#xD;
	&#xA0;&#xD;
&#xD;
</ArticleTitle><ArticleLanguage>English</ArticleLanguage><FirstPage>14</FirstPage><LastPage>19</LastPage><AuthorList><Author>Reddy Chandra Shekara</Author><AuthorLanguage>English</AuthorLanguage><Author> Srinivas Arun</Author><AuthorLanguage>English</AuthorLanguage><Author> Chawath Siddarth Kumar</Author><AuthorLanguage>English</AuthorLanguage></AuthorList><Abstract>&#xD;
	Introduction: Severe Calcific Aortic Stenosis (AS) remains a major cause of morbidity and mortality in aged population. Asymptomatic with reduced LVEF has high risk of sudden death. Aim: To study the complexity of clinical course of Severe Calcific AS with LV Dysfunction. Case Report: A Seventy-Six-year-old male was admitted with ACS, NSTEMI, LVEF 35% and Severe Calcific AS. With plan of AVR, CAG was done and showed Mild CAD. Post-procedure he had sequence of catastrophic clinical events that includes, A systolic Cardiac Arrest (reverted after CPR) and Protracted Pulmonary edema (Connected to Mechanical Ventilation). Later had Malignant Ventricular Arrhythmias, treated with 34 times DC Shocks. He was not suitable for Surgical AVR or TAVI. After high-risk consent, he successfully underwent emergency Aortic Balloon Valvuloplasty (ABV) with significant drop in AV gradients. Post ABV, also had Paroxysmal AF. Arrhythmias were also treated with Beta blocker, Antiarrhythmics, Digoxin and Potassium supplementation. Gradually stabilized, discharged and followed up. Discussion: Aortic stenosis, a disease of elderly age group. Symptomatology varies widely. It has limited management options. In our case, Post CAG critical illness was probably due to &#x201C;Pre -CAG&#x201D; LV dysfunction with subclinical symptoms. ABV used as bail out the procedure in high-risk patients. Conclusion: ABV is considered as a viable palliative option, with the introduction of smaller profile balloons, rapid pacing and vascular closure devices. ABV can safely used as bridging procedure before Surgical AVR or TAVI in high-risk patients&#xD;
&#xD;
</Abstract><AbstractLanguage>English</AbstractLanguage><Keywords>Aortic Balloon Valvuloplasty, Surgical Aortic Valve Replacement, Trans Aortic Valvular Implantation, Malignant Ventricular Arrhythmias</Keywords><URLs><Abstract>http://ijcrr.com/abstract.php?article_id=4676</Abstract><Fulltext>http://ijcrr.com/article_html.php?did=4676</Fulltext></URLs><References>&#xD;
	1. Dejam A, Hokinson M, Laham R. Repeated successful balloon valvuloplasty of a bioprosthetic aortic valve in a nonagenerian. Catheter Cardiovasc Interv. 2011 Mar 1;77(4):589-92doi: 10.1002/ccd.22816 &#xD;
&#xD;
&#xD;
&#xD;
	2. Otto Catherine M, Rick AN, Bonow RO, Carabello BA, Erwin 3rd JP, Gentile F et al. ACC/AHA guideline for the management of patients with valvular heart disease. J Am Coll Cardiol. 2020;77: e25-197.https://doi.org/10.1161/CIR.0000000000000923 &#xD;
&#xD;
&#xD;
&#xD;
	3. Tsampasian V, Grafton-Clarke C, Ramos AE, Asimakopoulos G, Garg P, Prasad S, et al. Management of asymptomatic severe aortic stenosis: a systematic review and meta-analysis. Open Heart. 2022 May 1;9(1): e001982. &#xD;
&#xD;
&#xD;
&#xD;
	4. http://dx.doi.org/10.1136/openhrt-2022-001982 5. Zilberszac R, Gabriel H, Schemper M, Laufer G, Maurer G, Rosenhek R. Asymptomatic severe aortic stenosis in the elderly. JACC: Cardiovascular Imaging. 2017 Jan;10(1):43-50.&#xD;
&#xD;
</References></Article></ArticleSet></xml>
